Boswellin®
The book titled Boswellin® The Anti-inflammatory Phytonutrient, written by M. Majeed et al., was published in 1996 by Nutriscience publishers, Inc. When this book was published, much of the patent literature concerning Boswellia serrata, its pharmacologically active constituents specifically known as β-boswellic acids, and similar species (B. carterii) was unavailable.
Research
Chemistry
The four major pentacyclic triterpenoids identified in Boswellin® are β-boswellic acid,Acetyl-β-boswellic acid, 11-keto-β-boswellic acid, Acetyl-11–keto–β-boswellic acid
Leukotriene Inhibition
The presence of a specific AKBA-binding site on 5-lipooxygense (5-LO) that is distinct from the arachidonate substrate-binding site was determined using photoaffinity labeling.
Mechanism of Action
Leukotrienes are fatty acids which are formed from arachidonic acid by an enzyme called 5-lipoxygenase(5-LO)
Newsroom
Latest News
Sabinsa Founder Dr. Muhammed Majeed Publishes Fourth Book on Boswellia
Sabinsa Granted Patent in Mexico on Boswellin® PS for Inflammation
Boswellin®
THE ANTI-INFLAMMATORY PHYTONUTRIENT